We are live on ! Find out more
BFRI icon

Biofrontera
BFRI

12 hedge funds and large institutions have $1.05M invested in Biofrontera in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

9% more funds holding

Funds holding: 11 → 12 (+1)

1.63% more ownership

Funds ownership: 21.33% → 22.97% (+1.6%)

37% less capital invested

Capital invested by funds: $1.67M → $1.05M (-$616K)

Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SC
Scotia Capital
Ontario, Canada
+$111K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$24.2K
3
UBS Group
UBS Group
Switzerland
+$13.8K
4
TRCT
Tower Research Capital (TRC)
New York
+$11.9K
5
Wells Fargo
Wells Fargo
California
+$116

Top Sellers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
-$18.8K
2
HF
HRT Financial
New York
-$16K
3
Renaissance Technologies
Renaissance Technologies
New York
-$16K

BFRI Hedge Fund Activity: Q2 2024 in Review

12 of the 6,936 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q2 2024, worth a combined $1.05M — down 37% from $1.67M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BFRI positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Scotia Capital, adding an estimated $111K. The largest seller was XTX Topco, exiting entirely with an estimated $18.8K sold.

  • 12 institutional investors held Biofrontera (BFRI) as of Q2 2024, up from 11 in Q1 2024.
  • Funds reported $1.05M of Biofrontera stock for Q2 2024, down 37% quarter-over-quarter.
  • 4 funds opened new Biofrontera positions in Q2 2024 and 3 closed out, a net change of +1 holder.
  • The largest Biofrontera buyer in Q2 2024 was Scotia Capital, an estimated $111K added.
  • The largest Biofrontera seller in Q2 2024 was XTX Topco, an estimated $18.8K sold.

Based on aggregated 13F filings for Q2 2024.